SEI Medical PCL (BKK:SEI) EBIT: ฿42.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SEI SEI Medical PCL BKK:SEI
19 GF Score
Price ฿1.78
! 3 Warning Signs
View Full Analysis

What is SEI Medical PCL EBIT?

SEI Medical PCL BKK:SEI -1.66% 19 EBIT is ฿42.8 Mil as of Mar. 2026. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

SEI Medical PCL's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ฿10.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ฿42.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SEI Medical PCL's annualized ROC % for the quarter that ended in Mar. 2026 was 10.91%. SEI Medical PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 19.37%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. SEI Medical PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.12%.


SEI Medical PCL  (BKK:SEI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SEI Medical PCL's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=40.48 * ( 1 - 20.64% )/( (270.102 + 319.075)/ 2 )
=32.124928/294.5885
=10.91 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=514.986 - 68.239 - ( 176.645 - max(0, 181.301 - 419.391+176.645))
=270.102

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=519.977 - 53.408 - ( 147.494 - max(0, 179.607 - 400.637+147.494))
=319.075

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

SEI Medical PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=41.98/( ( (58.295 + max(146.705, 0)) + (58.696 + max(169.65, 0)) )/ 2 )
=41.98/( ( 205 + 228.346 )/ 2 )
=41.98/216.673
=19.37 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(88.212 + 140.146 + 10.679) - (68.239 + 11.859 + 12.234)
=146.705

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(97.575 + 147.389 + 4.217) - (53.408 + 13.173 + 12.95)
=169.65

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

SEI Medical PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=42.813/265.528
=16.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SEI Medical PCL EBIT Related Terms


SEI Medical PCL EBIT Historical Data

* Premium members only.

The historical data trend for SEI Medical PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEI Medical PCL EBIT Chart

SEI Medical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT
25.36 30.77 68.64 60.63

SEI Medical PCL Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.31 10.53 14.07 7.72 10.50

BKK:SEI vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, SEI Medical PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SEI Medical PCL EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SEI Medical PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SEI Medical PCL's EV-to-EBIT falls into.


BKK:SEI
19GF Score
SEI Medical PCL BKK:SEI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SEI Medical PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿42.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ฿42.8 Mil mean?
SEI Medical PCL (BKK:SEI) has a EBIT of ฿42.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on SEI Medical PCL.
Is SEI Medical PCL's EBIT too high?
SEI Medical PCL's current EBIT is ฿42.8 Mil. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's EBIT compare to MCK and CAH?
SEI Medical PCL's EBIT of ฿42.8 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on SEI Medical PCL. SEI Medical PCL's current EBIT is ฿42.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current EBIT of ฿42.8 Mil. The current EBIT is ฿42.8 Mil. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current EBIT is ฿42.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SEI Medical PCL Business Description

Address Ratchadaphisek Road, No. 546 Ratchada One Building, 7th Floor, Chankasem, Chatuchak District, Bangkok, THA, 10900
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score

Get the complete analysis for BKK:SEI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.78
Price